Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir
|
It is a long-acting antiretroviral intended for
dosing twice a year by subcutaneous injection. In combination with other antiretrovirals ... |
Indigenous organization asking feds for $20 million to help control HIV crisis
Data from the Public Health Agency of Canada found that Saskatchewan and Manitoba had the highest rate of newly diagnosed HIV cases in 2022 — 19 ... View article...